Showing results (631-640 of 824) with videos related to

Sort By:
Pageof 83
Biomaterials Science|February 23, 2021
Heterogeneous toroidal spiral particles for islet encapsulationPaola Leon Plata, Maryam Zaroudi, Chun-Yin Lee, et al.
Plos One|December 19, 2017
Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's diseasePanagiotis Bargiotas, Lukas Eugster, Michael Oberholzer, et al.
Tissue Engineering. Part A|August 27, 2013
Beneficial effects of coating alginate microcapsules with macromolecular heparin conjugates-in vitro and in vivo studyVijayaganapathy Vaithilingam, Gabriela Kollarikova, Meirigeng Qi, et al.
Analytical and Quantitative Cytology and Histology|May 1, 1987
Morphometry and immunocytochemistryM Oberholzer, R A Ettlin, G Klöppel, et al.
Transplantation|April 13, 2000
Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantationsJ Oberholzer, F Triponez, R Mage, et al.
Cell Transplantation|May 11, 2005
Effect of microcapsule composition and short-term immunosuppression on intraportal biocompatibilityChristian Toso, Zoltan Mathe, Philippe Morel, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 29, 2012
Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRIKatja Oberholzer, Matthias Menig, Andreas Pohlmann, et al.
Pediatric Transplantation|October 23, 2021
Increased use of split liver grafts in adult recipients following implementation of a pediatric liver transplant programPaola Andrea Vargas, Jonathan Michael Cullen, Christina Dalzell, et al.
Therapeutische Umschau. Revue Therapeutique|January 1, 1993
[Incidence of drug side effects by symptoms and syndromes. From the experiences of the Comprehensive Hospital Drug Monitoring and the Swiss Drug Side Effect Center. As an example: allergic and pseudo-allergic reactions with mild analgesics and NSAID]B Oberholzer, R Hoigné, K Hartmann, et al.
Transplantation Direct|January 26, 2023
Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based ImmunosuppressionV Ram Peddi, Bradley Marder, Luis Gaite, et al.
Pageof 83